Deal News

Latest deal news and updates for US-listed public companies.

Rithm Capital Closes $482.6 Million Non-QM Loan Securitization

NEW YORK--(BUSINESS WIRE)--Rithm Capital Corp. (NYSE: RITM, “Rithm Capital” or the “Company”), a global, multi-dimensional asset manager with deep experience investing in real estate and credit, to...

What is the market’s perception of Rithm’s strategy to expand non‑QM exposure—does it signal a shift toward higher‑yield, higher‑risk assets? How does the involvement of Newrez LLC as servicer affect servicing‑fee revenue and net interest margin? Are there any regulatory or credit‑risk considerations specific to non‑QM loans that could influence investor sentiment?

Symbol: RITM

14 days ago

Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome's Blood-Based Screening Test for Colorectal Cancer

– Deal worth up to $885 million based on achievement of certain regulatory and screening guideline milestones – – Final module for the first version of Freenome's colorectal cancer test has been su...

How sensitive is the deal’s financial upside to macro‑economic factors or changes in healthcare policy? What impact could the launch have on Exact Sciences' existing product portfolio and sales focus? Are there any contingent earn‑out clauses or performance targets that could accelerate or defer payments under the agreement?

Symbol: EXAS

20 days ago